Your browser doesn't support javascript.
loading
On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer.
Boudghene-Stambouli, Fadia; Soulez, Mathilde; Ronkina, Natalia; Dörrie, Anneke; Kotlyarov, Alexey; Seternes, Ole-Morten; Gaestel, Matthias; Meloche, Sylvain.
Afiliação
  • Boudghene-Stambouli F; Institute for Research in Immunology and Cancer, Montreal, QC H3T 1J4, Canada.
  • Soulez M; Department of Pharmacology and Physiology, Université de Montréal, Montreal, QC H3C 3J7, Canada.
  • Ronkina N; Institute for Research in Immunology and Cancer, Montreal, QC H3T 1J4, Canada.
  • Dörrie A; Institute of Cell Biochemistry, Hannover Medical School, D-30625 Hannover, Germany.
  • Kotlyarov A; Institute of Cell Biochemistry, Hannover Medical School, D-30625 Hannover, Germany.
  • Seternes OM; Institute of Cell Biochemistry, Hannover Medical School, D-30625 Hannover, Germany.
  • Gaestel M; Department of Pharmacy, UiT The Arctic University of Norway, 9037 Tromso, Norway.
  • Meloche S; Institute of Cell Biochemistry, Hannover Medical School, D-30625 Hannover, Germany.
Cancers (Basel) ; 15(1)2022 Dec 21.
Article em En | MEDLINE | ID: mdl-36612022
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article